Suchergebnisse - "Niger, Monica"

PubPharm (109)

1

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence : PURITY study

enthalten in: BMC cancer | 2024

von Niger, M. | Nichetti, F. | Fornaro, L. | +34

2

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study

enthalten in: BMC cancer | 2024

von Niger, M. | Nichetti, F. | Fornaro, L. | +34

3

Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab

enthalten in: Targeted oncology | 2024

von Rimini, M. | Loi, E. | Rizzato, M. | +26

4

Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab

enthalten in: Targeted oncology | 2024

von Rimini, M. | Loi, E. | Rizzato, M. | +26

5

The Italian Rare Biliary tract Cancer initiative (IRaBiCa) : A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)

enthalten in: Tumori | 2024

von Speranza, D. | Sapuppo, E. | Aprile, G. | +34

6

Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements : A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Parisi, A. | Delaunay, B. | Pinterpe, G. | +42

7

NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer : A Systematic Review and Meta-Analysis

enthalten in: JAMA network open | 2024

von Nichetti, F. | Rota, S. | Ambrosini, P. | +13

8

Diagnosis and treatment of cholangiocarcinoma in Italy : A Delphi consensus statement

enthalten in: Critical reviews in oncology/hematology | 2023

von Rimassa, L. | Brandi, G. | Niger, M. | +3

9

Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors : the phase Ib trial MetNET2

enthalten in: Journal of hematology & oncology | 2023

von Pusceddu, S. | Corti, F. | Prinzi, N. | +25

10

Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Militello, A. | Orsi, G. | Cavaliere, A. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]